Thinking people

Our Think Tank brings together leading experts in artificial intelligence, biotechnology, and the pharmaceutical industry, united by a shared vision: to foster innovation and the responsible development of AI. With expertise ranging from scientific and epistemological research to technology, ethics, and regulatory affairs, we collaborate to shape the future of AI-driven solutions—ensuring safety, transparency, and tangible impact across life sciences and industrial applications.

Explainambiguity Think Tank is part of the Drug Target Review Advisory Board, represented by Dr. Remco Foppen. Meet the minds redefining the future of AI in healthcare and beyond.

Dr. Remco Jan Geukes Foppen

CO-FOUNDER
AI and life sciences expert specializing in the pharmaceutical sector. Member of the Drug Target Review Advisory Board.

Vincenzo Gioia

CO-FOUNDER
AI Innovation and Transition Manager, Senior Manager, Independent

Alessio Zoccoli

Senior Data Scientist - Tech Leader

Alberto Traverso

Head of RWE-RWD and AI clinical research | Oncology

Marcella Zucca

Life science, manufacturing and sustainability Capgemini I&D Italy

Paolo D'Ambrosio

Philosopher of science and epistemologist, specialized in philosophy of biology, explores the connections between AI, neuroscience and biocultural evolution.

Page updated

Google Sites

Report abuse